MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1.

Zhang, Zhixuan; Li, Haifeng; You, Jianqiang; Xue, Haixiang; Tan, Xiaoye; Chao, Changjiang

Zhang, Zhixuan; Li, Haifeng; You, Jianqiang; Xue, Haixiang; Tan, Xiaoye; Chao, Changjiang.

Afiliación

Zhang Z; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.
Li H; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.
You J; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.
Xue H; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.
Tan X; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.
Chao C; Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China.

Oncol Lett ; 21(5): 396, 2021 May.

Article en En | MEDLINE | ID: mdl-33777219

Palabras clave

doublecortin-like kinase 1; microRNA-223-5p; nasopharyngeal carcinoma; progression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2021 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google